COSA 2018: New research shows potential benefits of lung cancer screening for at risk groups
Cancer clinicians at the COSA ASM discussed the latest evidence in lung cancer screening, with new…
Browsing: lung cancer
Atezolizumab combination improves PFS for advanced NSCLC patients
Findings from a recent study demonstrate that the use of atezolizumab, a PD-L1 inhibitor, in…
The risk of lung cancer for young breast cancer survivors
Jean-Philippe Pignol, Dalhousie University and Nienke Hoekstra, Dalhousie University New research shows the risk of…
Will saliva translate to a real diagnostic tool?
In the era of new diagnostic methods and treatment options, patient care is rapidly changing.…
Lung cancer mortality rates among women projected to increase by over 40 percent by 2030
The global age-standardised lung cancer mortality rate among women is projected to increase by 43…
New finding could ‘pause and rewind’ lung cancer
A team of Institute researchers have discovered how to stop and reverse the growth of…
Association of complementary medicine, cancer treatment, survival
The use of complementary medicine by patients with four common cancers (breast, prostate, lung or…
Brain metastases common and difficult to treat in ROS1 lung cancer
Increasingly, doctors are treating lung cancer based on the genetic rearrangements driving the disease. For…
‘Slow but sure’ progress toward less toxic tools to fight cancer
John Ryan is just one of the miracles to emerge from the Johns Hopkins cancer…
More than 1 in 3 lung cancer patients present at emergency department around the time of diagnosis
A new study by Cancer Council NSW has revealed that over one in three lung…